These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1336974)

  • 1. New drug prophylaxis for M avium infection.
    Nurs Stand; 1992 Dec 9-15; 7(12):17. PubMed ID: 1336974
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifabutin receives treatment IND status for AIDS-related use.
    Ann Pharmacother; 1992 Jun; 26(6):868. PubMed ID: 1319245
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro and in vivo chemotherapeutic activity of rifabutin (LM 427) on Mycobacterium avium-intracellulare complex.
    Sakurai N; Kuze F
    Bull Chest Dis Res Inst Kyoto Univ; 1987 Mar; 20(1-2):50-60. PubMed ID: 2836007
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifabutin now available to patients with AIDS.
    Oncology (Williston Park); 1992 May; 6(5):90. PubMed ID: 1318065
    [No Abstract]   [Full Text] [Related]  

  • 5. [Activities of rifabutine and rifampicin against Mycobacterium avium complex infections in mice and in peritoneal macrophages].
    Saito H; Sato K; Tomioka H
    Kekkaku; 1988 Mar; 63(3):173-9. PubMed ID: 2836650
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnosis and management of mycobacterial infection and disease in persons with human T-lymphotropic virus type III/lymphadenopathy-associated virus infection.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Jul; 35(28):448-52. PubMed ID: 3088428
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of rifabutin on disseminated Mycobacterium avium infections in thymectomized, CD4 T-cell-deficient mice.
    Furney SK; Roberts AD; Orme IM
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1629-32. PubMed ID: 2178333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Resistance testing of M. avium-intracellulare and M. tuberculosis of AIDS patients with new drugs and drug combinations].
    Mauch H; Reichert B; Ruf B; Brehmer W
    Pneumologie; 1990 Feb; 44 Suppl 1():504-6. PubMed ID: 2114636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New antitubercular drugs].
    Krasucka-Kluźniak A
    Pneumonol Pol; 1990; 58(4-5):163-6. PubMed ID: 2168041
    [No Abstract]   [Full Text] [Related]  

  • 10. AIDS drug approved.
    J Am Osteopath Assoc; 1993 Feb; 93(2):261. PubMed ID: 8381779
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige mice.
    Gangadharam PR; Perumal VK; Podapati NR; Kesavalu L; Iseman MD
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1400-3. PubMed ID: 2848444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols].
    Tomioka H; Saito H
    Kekkaku; 1994 Nov; 69(11):703-10. PubMed ID: 7837724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs for tuberculosis.
    Treat Guidel Med Lett; 2004 Dec; 2(28):83-8. PubMed ID: 15557876
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimycobacterial activity in vivo of LM427 (rifabutin).
    Orme IM
    Am Rev Respir Dis; 1988 Nov; 138(5):1254-7. PubMed ID: 2849349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro activities of rifabutine and rifampicin against various mycobacteria, especially Mycobacterium tuberculosis and Mycobacterium avium complex].
    Saito H; Sato K; Tomioka H
    Kekkaku; 1988 Mar; 63(3):167-72. PubMed ID: 2836649
    [No Abstract]   [Full Text] [Related]  

  • 16. Progress report: prophylaxis and therapy for MAC.
    Currier J
    AIDS Clin Care; 1996 Jun; 8(6):45-8. PubMed ID: 11363599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H(37)Rv, MDR and NRP Mycobacterium tuberculosis.
    Figueiredo R; Moiteiro C; Medeiros MA; da Silva PA; Ramos D; Spies F; Ribeiro MO; Lourenço MC; Júnior IN; Gaspar MM; Cruz ME; Curto MJ; Franzblau SG; Orozco H; Aguilar D; Hernandez-Pando R; Costa MC
    Bioorg Med Chem; 2009 Jan; 17(2):503-11. PubMed ID: 19119013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antimycobacterial agents.
    Cynamon MH; Klemens SP
    Clin Chest Med; 1989 Sep; 10(3):355-64. PubMed ID: 2505963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium avium-intracellulare infection in the acquired immunodeficiency syndrome.
    Scoular A; French P; Miller R
    Br J Hosp Med; 1991 Nov; 46(5):295-300. PubMed ID: 1958928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifabutin (ansamycin LM 427): a new rifamycin-S derivative for the treatment of mycobacterial diseases.
    O'Brien RJ; Lyle MA; Snider DE
    Rev Infect Dis; 1987; 9(3):519-30. PubMed ID: 3037676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.